|Articles|February 15, 2002
Studies to determine if others may benefit from PDT
Cleveland-esearchers hope to expand on the benefits of photodynamic therapy (PDT) for patients with subfoveal choroidal neovascularization (CNV) in age-related macular degeneration (AMD), said Lawrence Singerman, MD
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Pickleball, fireworks, eyecare in space, and IRIS registry data among lead stories from day 1 of AAO 2025
2
Preclinical study suggests synaptic regeneration may offer new pathway to treat glaucoma
3
Tensions rise between STAAR and Broadwood as proposed Alcon deal nears vote
4
AAO 2025: The outcomes of the VERONA and DAVIO-2 studies set up continued phase 3 research
5